Brainsway Ltd. American Depositary Shares (BWAY)
- Headquarters
- United States
- Employees
- 129
- Market Cap
- $655M
About Brainsway Ltd. American Depositary Shares
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
SentiSense also tracks daily options readings for Brainsway Ltd. American Depositary Shares: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Brainsway Ltd. American Depositary Shares stock analysis, sentiment tracking, and market intelligence on SentiSense.